The present invention relates to a novel 3,4-dihydro-lH-naphthalene derivative having a structure of formula 1 or formula 2, its pharmaceutically acceptable salts and their geometric isomers as a highly selective cyclooxygenase-2 inhibitor. <CHEM> <CHEM> Wherein, R<1>, R<2>, X, A and Q are defined in this specification respectively.